These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 12165021
1. Detection and identification of oxalate-degrading bacteria in human feces. Kodama T, Akakura K, Mikami K, Ito H. Int J Urol; 2002 Jul; 9(7):392-7. PubMed ID: 12165021 [Abstract] [Full Text] [Related]
4. Molecular identification of Oxalobacter formigenes with the polymerase chain reaction in fresh or frozen fecal samples. Kwak C, Jeong BC, Lee JH, Kim HK, Kim EC, Kim HH. BJU Int; 2001 Oct; 88(6):627-32. PubMed ID: 11678762 [Abstract] [Full Text] [Related]
5. Identification of Oxalobacter formigenes in the faeces of healthy cats. Weese JS, Weese HE, Rousseau J. Lett Appl Microbiol; 2009 Dec; 49(6):800-2. PubMed ID: 19780961 [Abstract] [Full Text] [Related]
8. Molecular epidemiology of fecal Oxalobacter formigenes in healthy adults living in Seoul, Korea. Kwak C, Jeong BC, Kim HK, Kim EC, Chox MS, Kim HH. J Endourol; 2003 May; 17(4):239-43. PubMed ID: 12816588 [Abstract] [Full Text] [Related]
13. Stable expression of the oxc and frc genes from Oxalobacter formigenes in human embryo kidney 293 cells: implications for gene therapy of hyperoxaluria. Ye ZQ, Kong DB, Chen ZQ, Yao LF, Guo H, Yu X, Liu GL, Yang WM. Int J Mol Med; 2007 Oct; 20(4):521-6. PubMed ID: 17786282 [Abstract] [Full Text] [Related]
14. [Construction of oxalate-degrading intestinal stem cell population in mice]. Ye ZQ, Liu GL, Chen ZQ, Kong DB, Yao LF, Yu X. Zhonghua Yi Xue Za Zhi; 2009 Apr 28; 89(16):1130-4. PubMed ID: 19595148 [Abstract] [Full Text] [Related]
15. Gut-inhabiting bacterium Oxalobacter formigenes: role in calcium oxalate urolithiasis. Mittal RD, Kumar R. J Endourol; 2004 Jun 28; 18(5):418-24. PubMed ID: 15253809 [Abstract] [Full Text] [Related]
16. The construction of an oxalate-degrading intestinal stem cell population in mice: a potential new treatment option for patients with calcium oxalate calculus. Chen Z, Liu G, Ye Z, Kong D, Yao L, Guo H, Yang W, Yu X. Urol Res; 2012 Apr 28; 40(2):131-41. PubMed ID: 21892601 [Abstract] [Full Text] [Related]
17. Analysis of commercial kidney stone probiotic supplements. Ellis ML, Shaw KJ, Jackson SB, Daniel SL, Knight J. Urology; 2015 Mar 28; 85(3):517-21. PubMed ID: 25733259 [Abstract] [Full Text] [Related]
18. Diversity of faecal oxalate-degrading bacteria in black and white South African study groups: insights into understanding the rarity of urolithiasis in the black group. Magwira CA, Kullin B, Lewandowski S, Rodgers A, Reid SJ, Abratt VR. J Appl Microbiol; 2012 Aug 28; 113(2):418-28. PubMed ID: 22616725 [Abstract] [Full Text] [Related]
19. Oxalate-degrading enzymes from Oxalobacter formigenes: a novel device coating to reduce urinary tract biomaterial-related encrustation. Watterson JD, Cadieux PA, Beiko DT, Cook AJ, Burton JP, Harbottle RR, Lee C, Rowe E, Sidhu H, Reid G, Denstedt JD. J Endourol; 2003 Jun 28; 17(5):269-74. PubMed ID: 12885351 [Abstract] [Full Text] [Related]
20. Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis. Miller AW, Choy D, Penniston KL, Lange D. Kidney Int; 2019 Jul 28; 96(1):180-188. PubMed ID: 31130222 [Abstract] [Full Text] [Related] Page: [Next] [New Search]